-transparent.png){kind=logo}
The anticonvulsive drug, valproic acid, inhibits competitively the pyruvate carrier in rat brain and liver mitochondria. Due to this inhibition the oxygen consumption supported by pyruvate oxidation is also affected. In our experimental conditions, pyruvate oxidation is partially inhibited by VPA concentration as low as 0.05 mM. Valproic acid, however, is unable, even at 10 mM, to fully inhibit pyruvate oxidation. Concentrations of VPA higher than 1 mM have an uncoupling effect on mitochondrial respiration. The oxidation of other mitochondrial substrates such as isocitrate, 2-ketoglutarate, DL-3-hydroxybutyrate and succinate is uncoupled but not inhibited by VPA. The effects of VPA on mitochondrial metabolism may be related to the therapeutic and/or toxicologic properties of this drug.
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
October 2008,
FEBS letters,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
October 1995,
Epilepsy research,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
May 1982,
Brain research,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
September 1964,
The Journal of biological chemistry,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
December 1982,
Mechanisms of ageing and development,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
April 1971,
Biochemical medicine,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
January 1976,
Acta biochimica Polonica,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
March 1996,
The Journal of pharmacology and experimental therapeutics,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
January 2004,
Epilepsy research,
J Benavides, and
A Martin, and
M Ugarte, and
F Valdivieso
July 1981,
Journal of neurochemistry,
